Author

Jeffrey B. Ulmer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Afshana QuadiriiD· 3 shared Daniel Gil· 3 shared Hawa VahediD· 3 shared Lbachir BenMohamediD· 3 shared Swayam PrakashiD· 3 shared Anthony B. Nesburn· 2 shared Aziz Alami ChentoufiiD· 2 shared Baruch D. Kuppermann· 2 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Afshana QuadiriORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyHuman Vaccines & ImmunotherapeuticsPeer-reviewedJul 4, 2025

A Pan-Beta-Coronavirus Vaccine Bearing Conserved and Asymptomatic B- and T-Cell Epitopes Protect Against Highly Pathogenic Delta and Highly Transmissible Omicron SARS-CoV-2 Variants of Concern.

Hawa Vahed, Swayam Prakash, Afshana Quadiri…·Lbachir BenMohamed

This paper develops a multi-epitope vaccine targeting conserved B- and T-cell epitopes from SARS-CoV-2, showing protection against Delta and Omicron variants in a mouse model.

9 citationstop 2%

mouseproteomics

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedFeb 18, 2025

Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19

Latifa Zayou, Swayam Prakash, Hawa Vahed…·Lbachir BenMohamed

This study identifies conserved B-cell epitopes on the SARS-CoV-2 Spike protein that elicit strong neutralizing antibodies and provide protection against the Delta variant in a mouse model.

11 citationstop 2%

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 14, 2024

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model

Swayam Prakash, Nisha Rajeswari Dhanushkodi, Mahmoud Singer…·Lbachir BenMohamed

This paper develops a multi-antigen mRNA/LNP-based pan-CoV vaccine that provides cross-protective immunity against multiple SARS-CoV-2 variants in a hamster model.

10 citations

mouseexperimental assay

𝕏 PostBluesky